Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Post

Showing results (501-510 of 535) with videos related to

Pageof 54
Sort By:
Lancet (London, England)|July 27, 2020
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trialKenneth H Mayer, Jean-Michel Molina, Melanie A Thompson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Predictors of renal outcome in HIV-associated nephropathyFrank A Post, Lucy J Campbell, Lisa Hamzah, et al.
Journal of Inherited Metabolic Disease|January 18, 2023
MOGS-CDG: Quantitative analysis of the diagnostic Glc<sub>3</sub> Man tetrasaccharide and clinical spectrum of six new casesMerel A Post, Isis de Wit, Fokje S M Zijlstra, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
The Journal of Infectious Diseases|October 3, 2017
Evaluating the Impact of Functional Genetic Variation on HIV-1 ControlPaul J McLaren, Sara L Pulit, Deepti Gurdasani, et al.
Plos Medicine|October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
The Lancet. HIV|January 7, 2023
Recommendations for defining preventable HIV-related mortality for public health monitoring in the era of Getting to Zero: an expert consensusSara E Croxford, Veronique Martin, Sebastian B Lucas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2021
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research WorkshopDaniel D Von Hoff, Gary M Clark, Charles A Coltman, et al.
Frontiers in Neurology|June 24, 2021
NANS-CDG: Delineation of the Genetic, Biochemical, and Clinical SpectrumBibiche den Hollander, Anne Rasing, Merel A Post, et al.
Marine Genomics|October 4, 2017
Cross-disciplinarity in the advance of Antarctic ecosystem researchJ Gutt, E Isla, A N Bertler, et al.
Pageof 54

Showing results (501-510 of 535) with videos related to

Sort By:
Pageof 54
Lancet (London, England)|July 27, 2020
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trialKenneth H Mayer, Jean-Michel Molina, Melanie A Thompson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Predictors of renal outcome in HIV-associated nephropathyFrank A Post, Lucy J Campbell, Lisa Hamzah, et al.
Journal of Inherited Metabolic Disease|January 18, 2023
MOGS-CDG: Quantitative analysis of the diagnostic Glc<sub>3</sub> Man tetrasaccharide and clinical spectrum of six new casesMerel A Post, Isis de Wit, Fokje S M Zijlstra, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
The Journal of Infectious Diseases|October 3, 2017
Evaluating the Impact of Functional Genetic Variation on HIV-1 ControlPaul J McLaren, Sara L Pulit, Deepti Gurdasani, et al.
Plos Medicine|October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
The Lancet. HIV|January 7, 2023
Recommendations for defining preventable HIV-related mortality for public health monitoring in the era of Getting to Zero: an expert consensusSara E Croxford, Veronique Martin, Sebastian B Lucas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2021
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research WorkshopDaniel D Von Hoff, Gary M Clark, Charles A Coltman, et al.
Frontiers in Neurology|June 24, 2021
NANS-CDG: Delineation of the Genetic, Biochemical, and Clinical SpectrumBibiche den Hollander, Anne Rasing, Merel A Post, et al.
Marine Genomics|October 4, 2017
Cross-disciplinarity in the advance of Antarctic ecosystem researchJ Gutt, E Isla, A N Bertler, et al.
Pageof 54